Cefotetan-induced hemolytic anemia after bariatric procedures

Surgery for Obesity and Related Diseases

Volumn 2, Issue 3, 2006, Pages 393-396

  Allen, Jeff W ^a   Acosta, Jorge ^a   Casós, Steven R ^a   Baldwin, Laura L ^a   Cacchione, Robert N ^a   Rodriguez, Jorge L ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Anemia; Bariatric surgery; Cefotetan; Gastric bypass; Weight loss procedure

Indexed keywords

CEFAZOLIN; CEFOTETAN; STEROID;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD TRANSFUSION; CASE REPORT; COOMBS TEST; DIZZINESS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; GASTRIC BANDING; HEMOLYSIS; HEMOLYTIC ANEMIA; HOSPITAL DISCHARGE; HUMAN; LAPAROSCOPIC SURGERY; PALLOR; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STOMACH BYPASS; SURGICAL INFECTION;

ADULT; ANEMIA, HEMOLYTIC; ANTI-BACTERIAL AGENTS; BARIATRIC SURGERY; CEFOTETAN; FEMALE; HUMANS; MIDDLE AGED; PERIOPERATIVE CARE; SURGICAL WOUND INFECTION;

EID: 33744540791     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2006.03.001     Document Type: Article

References (15)

1. Viraraghavan R., Chakravarty A.G., and Soreth J. Cefotetan-induced haemolytic anemia. a review of 85 cases. Adv Drug React Toxicol Rev 21 (2002) 101-107
2. Silver A., Eichorn A., Kral J., et al., Antibiotic Prophylaxis Study Group. Timeliness and use of antibiotic prophylaxis in selected surgical procedures. Am J Surg 171 (1996) 548-552
3. Polk Jr. H.C., and Christmas A.B. Prophylactic antibiotics in surgery and surgical wound infections. Am Surg 66 (2000) 105-111
4. Podnos Y.D., Jimenez J.C., Wilson S.E., Stevens M., and Nguyen N.T. Complications after laparoscopic gastric bypass. a review of 3464 cases. Arch Surg 138 (2003) 957-961
5. Arndt P.A., and Garratty G. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other. cephalosporins and penicillin. Am J Clin Pathol 118 (2002) 256-262
6. Moes S.G., and MacPherson B.R. Cefotetan-induced hemolytic anemia. a case report and review of the literature. Arch Pathol Lab Med 124 (2000) 1344-1346
7. Stroncek D., Procter J.L., and Johnson J. Drug-induced hemolysis. cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction. Am J Hematol 64 (2000) 67-70
8. Pories W.J., van Rij A.M., Burlingham B.T., Fulghum R.S., and Meelheim D. Prophylactic cefazolin in gastric bypass. Surgery 90 (1981) 426-432
9. Edmiston Jr. C.E. Microbiology of intraabdominal infections. Infect Dis Clin Pract 5 suppl (1996) 515-519
10. Wanger B.K., Heaton A.L., and Flink J.R. Cefotetan disodium-induced hemolytic anemia. Ann Pharmacother 26 (1992) 199-200
11. Garratty G., Nance S., and Lloyd M. Fatal immune hemolytic anemia due to cefotetan. Transfusion 32 (1992) 269-271
12. Arndt P.A. Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone. a case study approach. Immunohematology 18 (2002) 27-32
13. Faich F.A. Adverse-drug-reaction monitoring. N Engl J Med 314 (1986) 1589-1592
14. Mangram A.J., Horan R.C., Pearson M.L., Silver L.C., Jarvis W.R., and Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20 (1999) 250-278
15. DeTorres O.H. Hemolytic anemia and pancytopenia induced by cefoxitin. Drug Intell Clin Pharm 17 (1983) 816-818